Skip to content

Effectiveness of Using a Chatbot to Promote Adherence to Home Physiotherapy

Herramienta De Procesamiento De Lenguaje Natural En Dispositivo Móvil Inteligente Para Fomentar La Adherencia a La Rehabilitación Domiciliaria

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05363137
Enrollment
65
Registered
2022-05-05
Start date
2022-09-01
Completion date
2024-06-01
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

A Chatbot oriented to virtually assist patients in a physiotherapy treatment has been designed and developed to interact with patients with musculoskeletal disorders in need for domiciliary rehabilitation. The tool has been designed to promote adherence to rehabilitation, what in turn may have an impact on clinical outcome. A randomized clinical trial involving patients undergoing total knee replacement has bee designed to determine the applicability of the proposal. The participants will be assigned into exerimental group (intervention with the software tool) or control group (standard care).

Interventions

OTHERChatbot Assistant

The physiotherpy treatment will be supervised via chatbot

OTHERStandard care

The physiotherpy treatment will be standard care

Sponsors

Ministerio de Ciencia e Innovación, Spain
CollaboratorOTHER_GOV
University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

* Individuals on the waiting list for total knee replacement surgery * Undergoing primary total knee replacement surgery * Who have a personal smartphone * Who have an instant messaging application installed * Familiar with the use of such application (more than 3 accesses per week),

Exclusion criteria

* Evident cognitive state that prevents to understand care provider instructions * Vestibular or central nervous system affection (e.g. stroke) * Cannot read or write * Do not understand Spanish language * Not able to consent to participate

Design outcomes

Primary

MeasureTime frameDescription
AdherenceChange from baseline to 3 months after surgery dateCompliance with intervention measured as the percentage of sessions carried out with respect to the total planned

Secondary

MeasureTime frameDescription
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Change from baseline to 3 months and one year after surgery dateSelf-administered questionnaire consisting of 24 items divided into pain, stiffness and physical function will register self-reported status. The score is given from 0 to 100
Knee PainChange from baseline to 3 months and one year after surgery dateMeasured with a visual analogue scale of pain, being 0 no pain and 10 the worst possible pain

Other

MeasureTime frameDescription
International Physical Activity Questionnaire (IPAQ-E)Change from baseline to 3 months after surgery dateThis questionnaire is used to measure the types of intensity of physical activity and sitting time as part of the participants' daily lives, i.e. the total physical activity in MET-min/week and time spent sitting
SafetyBaseline (surgery day) to 12 monthsAdverse events, defined as any unfavorable or unintended diagnosis, sign, symptom, or disease associated with the study
System UsabilityChange from baseline to 3 months after surgery dateSystem usability scale will be used for measuring the usability; this consists of a 10 item questionnaire with five response options from Strongly agree to Strongly disagree
Feasibility_1Time from initial day to last day of recruitment up to two yearsRecruitment rate, obtained by dividing the number of participants divided by the number patients invited
Feasibility_2Time from initial day to 3 months after surgery dateRetention rate, obtained by dividing the number of participants assessed at three months by the total number of participants

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026